Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanomas
Technology
E-302-2000
Patent ID
E-302-2000-2-US-04
Country
US
Application Type
DIV
Patent Status
Expired
Patent Number
7612035
Publication Number
US-2005-0267012-A1
Application Number
11/155,691
IC
NCI
Date Filed
Date Issued